• PULL secures edible cannabis gummies order from British Columbia Liquor Distribution Branch
• PULL’s cannabis gummies produced in blister packs using proprietary manufacturing system licensed from US-based Taste-T, LLC
• SKUs include 10 mg THC options in Fire Burst, Strawberry, and Mango flavors, three additional non-THC SKUs currently in development
• Global CBD gummies market estimated at $1.6 billion in 2020, 30.7% CAGR from 2021 to 2028

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging psychedelic sector, recently secured an initial purchase order through subsidiary Pure Extracts Manufacturing Corp., from the British Columbia Liquor Distribution Branch (“LDB”) for its edible cannabis gummies (https://ibn.fm/xQwPw). Packaged in convenient blister packs, the products use a proprietary manufacturing system licensed from US-based Taste-T, LLC, with 10 mg THC options that include Fire Burst, Strawberry, and Mango flavors. “The edible gummie business is a material revenue producer for Pure Extracts,” said Pure Extracts CEO Ben Nikolaevsky. “We are excited to have received our first purchase order for Fire Burst cinnamon flavored gummies from the wholesaler serving our home province of British Columbia, the LDB, adding them to our provincial distribution and look forward to a successful long-term relationship that leads to a satisfied customer base. With our proprietary manufacturing and packaging machine and our high-quality cannabis extracts, we have created the type of exceptional gummie products that consumers now demand.” Consumer demand for PULL’s Pure Chews branded THC and CBD gummies is strong and continues to grow throughout provincial markets. The Company anticipates that its Fire Burst flavor, like its US counterpart, Taste-T’s, Fireball Cinnamon, will become a best seller across Canada. The global gummies market has experienced staggering growth among consumers wishing to experience the benefits of CBD (https://ibn.fm/itTZJ) without the negative effects of smoking flowers or using vaping devices. Grandview Research valued the global CBD gummies market at $1.6 billion in 2020 and estimates a CAGR of 30.7% from 2021 to 2028 (https://ibn.fm/ucnPy). Pure Extracts expects sales from their initial production run of 50,000 packs to reach $200,000 in revenue from sales in British Columbia, Alberta, Saskatchewan and Ontario, and plans to launch additional non-THC SKUs with varying levels of ultra-high potency CBD in the near future (https://ibn.fm/WQouF). “We plan to replicate the success that our licensing partner, Taste-T, is experiencing in US states including Nevada, Massachusetts, Michigan and Oklahoma,” said Nikolaevsky. “Our exceptionally pure products are in high demand and we have a range in potencies and flavors that consumers will certainly enjoy.” Based in Pemberton, British Columbia, Pure Extracts engages in cannabis toll processing, production of private label THC and CBD-based cannabis products, functional mushroom supplement production and sales, white labeling, and recent developmental activities into the psychedelic mushrooms sector. The Company’s extraction facility is built to European Union GMP standards to secure EU GMP certification for exports to European countries where their products are legal. For more information, visit the company’s website at www.PureExtractsCorp.com. NOTE TO INVESTORS: The latest news and updates relating to PULL are available in the company’s newsroom at https://ibn.fm/PULL

• BevCanna expanding distribution of TRACE mineral-rich beverages, supplements into U.S. through new distribution agreement with Benefit Brand Management
• TRACE products feature proprietary plant-based mineral-rich formula sourced from British Columbia’s Rocky Mountains
• Company announced approximated forecasts of $2.4 million revenue, $0.63 million gross profit, based on annual minimum order quantities, committed order queue, and does not include contracts that are yet to be finalized or under negotiation.

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) is a diversified health & wellness beverage and natural products company focused on developing and manufacturing a range of plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients. The company recently announced expanded distribution of their TRACE products into the United States through a new agreement with leading wholesaler Benefit Brand Management (https://ibn.fm/JrWT1) along with forecasts of $2.4 million in revenue and $0.63 million in gross based on annual minimum order quantities and its committed white-label beverage order queue (https://ibn.fm/B8Mx2). BevCanna creates, manufactures, and globally distributes iconic beverages that resonate with a health-conscious and well-informed demographic. Sourced from deep within the Rocky Mountains of interior British Columbia, the company’s TRACE line of beverages and nutraceuticals are formulated with a proprietary plant-based formula rich in iron, magnesium, calcium and potassium, designed to appeal to consumers seeking mineral supplementation as a result of mineral deficiencies in the modern food supply. As part of its expansion strategy, the company recently finalized an agreement with leading North American brand and sales management firm Benefit Holdings LLC, dba Benefit Brand Management, to distribute the TRACE line of products in the United States. Starting with health-conscious consumers in New York, Chicago and California, the company has plans to expand its footprint to a growing range of retailers spanning independent specialty retailers to national big-box outlets. “With demand for wellness-focused beverages rapidly increasing among U.S. consumers, this is the ideal time to introduce the TRACE brand to a whole new demographic,” said BevCanna President Melise Panetta. “We’re very excited to work with Benefit on launching the brand, capitalizing on their extensive network and detailed knowledge of the natural products retail landscape in the U.S.” BevCanna also announced forecasts of approximately $2.4 million in revenue and $0.63 million in gross profit for the rolling 12 months starting in July 2021. The company based these figures on annual minimum order quantities for both its Canadian cannabis and Naturo Group white-label beverage operations, including any orders in the company’s queue, less any unfinalized contracts or agreements under negotiation. “We’re thrilled with the progress that we’ve made in securing commitments for both our cannabis-infused and traditional beverage white-label operations,” said Panetta. “There has been strong demand for both operations, and we’re ramping up commercial production for signed clients, with more active customer discussions underway. We’re ready and eager to start production within the month and expect to see products on shelves for the summer season.” Based in British Columbia, BevCanna owns a pristine alkaline spring water aquifer and a world-class HACCP-certified 40,000-square-foot manufacturing facility with an annual 210-million bottling capacity. The company’s extensive retail network spans 3,000+ points of distribution throughout North America. These include its market-leading TRACE brand, its Pure Therapy natural health and wellness e-commerce platform, its fully licensed Canadian cannabis manufacturing and distribution network, and a partnership with Keef Brands, the #1 cannabis beverage company in the United States. For more information, visit the company’s website at www.BevCanna.com. NOTE TO INVESTORS: The latest news and updates relating to BVNNF are available in the company’s newsroom at http://ibn.fm/BVNNF

• Taking place Saturday, June 26 at Green Karma Farm in Orange, Mass.
• About 40 cannabis industry vendors registered: more spaces still available
• Hosted by The New England Cannabis Convention (NECANN), the largest cannabis and hemp event series in the United States
• Massachusetts is a pioneering adult recreational cannabis use state

When Massachusetts’ voters gave the green light to legalizing adult recreational marijuana use in 2016, the state stood alone among its East Coast neighbors as a place where cannabis cravers could freely pursue their passion. According to the Boston Globe, marijuana sales have since risen to nearly $1.5 billion in total (https://ibn.fm/li6Wx). Massachusetts is no longer unique in its approach to legalizing the leafy green plant, however, and the New England Cannabis Convention (NECANN) has grown to become the largest cannabis and hemp event series in the United States. Its members actively promote legislation favorable to the industry throughout the Northeastern United States, including Massachusetts, particularly on behalf of small cottage industry growers. On Saturday, June 26, NECANN will host its BeanCon event as a one-day gathering for bud buyers and sellers at the Green Karma Farm (210 Wheeler Ave) in Orange, Mass. BeanCon is one in a series of events NECANN has planned to help promote small business operations from Maine to Oklahoma during the coming year. Orange, situated some 70 miles inland from Boston, is bisected by a river and steeped in the New England history. Green Karma Farm is putting a new-old face on the townscape, serving area residents with its mission to provide natural goodness through free-range eggs, CBD products and yoga classes. The home-grown feel of such small businesses provides a bit of pandemic pain relief in the form of greater human connection and a quieter pace of living. The pandemic is reputed to have driven sales of cannabis higher as users look for ways to ease anxiety and physical discomforts that the health emergency’s strictures have brought. BeanCon will be an outdoor event where all attendees and vendors will be required to follow all state COVID safety guidelines regarding in-person capacity limits, protective clothing and interpersonal distancing. BeanCon will nevertheless be a friendly opportunity for cannabis fans to network while browsing the full plant and product displays, shopping at the seed, clone and tissue culture, soil, nutrients and growing aids booths. About 40 vendors are signed up to present at the event, and several booth spaces are still available within the floorplan’s limits. “The show is drawing more quality exhibitors and that leads to better networking. We had a couple of new deals that we struck up that will have a big impact on our business going forward. More out of state customers, investors and engineering are interested in locating in MA and we meet them here,” Gary Arnold of TSRgrow stated. Tickets are $20 and can be obtained through BeanCon’s website, https://necann.com/beancon/

Date: June 16-18, 2021 Virtual Event Event Highlights

• The virtual event aims to promote the attainment of pre-launch excellence in strategic cross-functional alignment by optimizing publication strategies and supporting product approvals
• The three-day event adopts a half-day format to maximize retention and engagement
• It will feature two 15-minute networking and coffee breaks daily, complemented by a virtual platform that supports an array of networking features beyond the capabilities of a Zoom meeting
• The event will take a broad educational approach in which 25+ facilitators will provide industry insights through case studies, presentations, Q&A sessions, and panel discussions

The 6th Annual Pharmaceutical & Biotech Medical Affairs Pre-Launch Strategies Conference, a three-day virtual event to be held June 16-18, 2021, focuses on achieving pre-launch excellence in strategic cross-functional alignment by optimizing publication strategies and supporting, at an evidentiary level, the approval of products. Organized by Q1 Production, the event will take an educational approach, comprising case studies, panel discussions, Q&A sessions, and presentations, and feature a half-day format for the three days to maximize engagement and retention. Further, it will be held on the Q1 Productions virtual event app that enhances both collaboration and networking. As a three-day event, the agenda is divided into three modules, each representing a day’s program. The event will kick off with a presentation on the Innovative approaches for enhanced HCP engagement, of course, after the opening remarks from Q1 Productions. A second presentation will follow 45 minutes later in which Brant Jarrett, PhD, Executive Director, Head of Field Medical Affairs at Mallinckrodt Pharmaceuticals (OTC: MNKKQ), will explore how to shape new pre-launch processes following the disruption caused by the COVID-19 pandemic. A 15-minute coffee and networking break will follow. Day one will continue in earnest thereafter, with a video chat featuring a panel of three facilitators, followed by three other presentations. In all, the first day will feature nine speakers drawn from various companies that deal with pharmaceuticals, biotechnology, and medical affairs. Module 2 will begin with a two-part session series titled Practical approach to investigator-initiated trial integration into the medical strategy; the second part will be a panel discussion. In total, day two will feature two panel discussions and three presentations by ten speakers holding senior positions in at companies like Taiho Oncology, Mallinckrodt Pharmaceuticals, Daiichi Sankyo (TYO: 4568), Alkermes PLC (NASDAQ: ALKS), Coherus Biosciences Inc (NASDAQ: CHRS), and more. Day three’s program will include presentations and panel discussions from seven speakers, who will explore the following topics: natural language processing, product differentiation in highly competitive markets, partnering to maximize data relevance and payer adoption, and, lastly, collaborating with the patient advocacy department to expose gaps in medical strategies. Q1 Productions, an event organizer leveraging more than 15 years’ experience to deliver educational programming across job functions and industries through curated events, understands attendees’ needs. In this regard, Q1 has facilitated the customization of attendees’ experiences and provided an opportunity for them to get answers to their unique concerns by integrating Q&A sessions into the program, particularly after every presentation or panel discussion. Furthermore, there will be two 15-minute networking and coffee breaks daily. These breaks, coupled with the features on its virtual platform that promote collaboration, are bound to make the conference an interactive and fun experience for everyone in attendance. Attendees should expect to learn about the blueprints that ensure the objectives of R&D and commercial teams remain cardinally aligned to the goals of an organization and how their peers ethically distribute scientific information about products to stakeholders. In sum, this curated conference is exquisitely loaded with a mixed bag of informative and networking sessions ideal for players in the medical affairs and medical science liaison professions. For more information regarding the event, visit https://ibn.fm/EuzVq

• California-based autonomous security robot developer Knightscope has joined its artificial intelligence know-how to a nationwide trend of using autonomous robots to manage some business decision making functions
• Knightscope’s ASR robots operate 24 / 7, 365 days a year in a property-protection capacity, employing a non-threatening “personality” to establish themselves as welcome participants in the community while also responding to incidents of concern
• Knightscope’s technological capabilities allow its ASR robots to monitor, analyze, record, transmit and receive a variety of data inputs that help it and its human operators discourage crime and more effectively respond when crime occurs
• The company’s most visible mobile model will soon receive a fifth-generation rollout, and the company is in the process of establishing or renewing technological contracts that define the ASRs’ capabilities

The need to keep public areas safe is an ever-present concern, and one that affects small communities as well as their metropolitan counterparts. Council Bluffs, Iowa, part of a larger metro area that includes nearly a million people, recently announced it will invest almost $3 million in upgrading security equipment for its public school district that has existed since 1859 (https://ibn.fm/P0yI7), making it part of a trend that has seen the use of security cameras on school premises increase from 19 percent of respondents in the 1999-2000 school year to 83 percent in 2017-18, and access controls increase from 75 percent to 95 percent during the same time period (https://ibn.fm/eTsJg). The trends portray a nationwide effort to drastically reduce violence and crime in public school settings during the two decades since the 1999 Columbine, Colorado high school shootings and attempted bombing that killed several students and a teacher, leaving education officials and the nation at large stunned in its wake (https://ibn.fm/C258P). Terroristic acts against individuals in other public settings, ranging from the deadly truck bombing of an Oklahoma City federal building four years before Columbine (https://ibn.fm/CxdWP) to a mass shooting at a San Jose workplace last month (https://ibn.fm/gvrHl), have fueled increasingly passionate political debates about security measures vs. Constitutional rights. In response to the current cultural climate, autonomous security robot (“ASR”) innovator Knightscope has declared its mission to make the nation safer through vigilance and community-friendly robotics. Knightscope’s visionary emphasis on technology in the security field has resulted in three developed ASR models and another one in the development process, with differing capabilities for monitoring indoor and outdoor environments at client facilities. The ASR robots are capable of monitoring, analyzing, recording, transmitting and receiving a variety of data inputs while presenting themselves as friendly members of their social environments. The robots have served clients ranging from private sector apartment complexes to government hospital facilities. A recent news report in Phoenix noted a Knightscope K5 autonomous outdoor security robot nicknamed Parker has been patrolling Park Central and surrounding environs for the past month, delivering 24/7 surveillance and a sense of safety and security for students and office workers. “He is in and out of Park Central. We go all the way from Central Avenue to 3rd [Avenue], almost to Osborn and almost to Thomas. It’s a big development. Parker is everywhere, and he doesn’t miss a beat. … He can take pictures of license plates. If he sees something inappropriate, he can connect right away on that, and our folks on site can step in and can help,” property manager Plaza Companies’ Chairman and CEO Sharon Harper told a local Fox News affiliate (https://ibn.fm/1o7j6). Analysts anticipate the development of autonomous mobile robots (“AMRs”), including ASRs, will only increase in coming years as the Fourth Industrial Revolution, or Industry 4.0, establishes an economic infrastructure with self-improving processes for “matching jobs to be done with the right workers, in the right place, at the right time” while AMRs take on much of the AI-driven decision making of their human colleagues (https://ibn.fm/S2fWF). Knightscope’s ASR models expect to be a key driver of the new economic engine, and the company has secured the backing of more than 28,000 investors in capital raises since its inception in 2013. For more information, visit the company’s website at www.Knightscope.com and if you have a need for subscription service you may request a private demonstration of the technology at www.Knightscope.com/demo. NOTE TO INVESTORS: The latest news and updates relating to Knightscope are available in the company’s newsroom at https://ibn.fm/Knight

• Infobird recently entered into a cooperative agreement with SaSa (China) Cosmetics Co., Ltd., to provide marketing and customer service solutions for the retailer’s sales staff/shopping guides
• The solutions’ benefits include enhanced trustworthiness, brand image, and value; improved call-through rates; efficient customer service management; and more personalized customer engagement experiences
• Through the agreement, SaSa will leverage technology to improve customer interactions and offer premium personalized experiences, effectively making it a customer experience leader in China

A 2018 KPMG study demonstrated that for a company to be a customer experience leader in China, it must have successfully leveraged technology to improve its interactions with customers, driven efficiency to enhance its customer offerings, and offered premium personalized experiences to meet the ever-growing expectations of customers (https://ibn.fm/zq2d0). Through its artificial intelligence (“AI”) enabled end-to-end customer engagement solutions, Infobird (NASDAQ: IFBD), a Software-as-a-Service company in China, is empowering companies to customer experience leadership as its new cooperative partnership with SaSa Cosmetics (China) Co., Ltd., a wholly owned subsidiary of SaSa International Holdings Limited that currently operates physical stores in multiple cities across China, demonstrates. The partnership, geared towards delivering better customer service and marketing capabilities, will help SaSa optimize its marketing and customer engagement model (https://ibn.fm/Bh44v). To achieve this goal, Infobird is providing marketing and customer service solutions for sales staff/shopping guides (“agents”), covering several products and services, including Infobird Cloud Call Center, automated intelligent quality inspection, AI voice chatbots, and intelligent training. These solutions are expected to improve customer interaction/experience and the efficiency of the agents and increase management effectiveness in stores. With the Infobird Cloud Call Center, for instance, SaSa’s agents will use a unified telephone system that enables them to manage customer service and marketing anytime from a mobile office, eliminating the limitations of traditional customer service centers, which restricted operations to a single location. Whenever the agents initiate customer service through the platform, customers will see a unified external name and number on their phones, which is likely to improve SaSa’s brand image, value, and trustworthiness as well as increase the call-through rate. Further, the system can automatically record all the agents’ communication and generate multi-dimensional analysis reports, resulting in improved customer service quality and experience; SaSa’s managers can track and understand the agents’ work in a timely fashion with the customizable reports. In addition to helping managers improve customer service management efficiency and resource allocation, Infobird’s multi-dimensional approach to customer data analysis allows its client to provide more personalized services according to the customers’ needs. According to a 2020 blog post (https://ibn.fm/subdi), the company’s solution achieves the latter by integrating quality inspection data with relevant business system data to generate multi-dimensional user profiles that provide the basic information and needs of the customers. This feature eliminates the need for the agents to constantly communicate or confirm their customers’ identities. Infobird has also adopted a new customer management mindset model to assist its client in improving marketing performance throughout the customer engagement journey. The cooperative partnership with SaSa Cosmetics (China) Co., Ltd, whose parent company is an influential cosmetics retail and beauty service group in Asia with operations in Hong Kong and Macau, Malaysia, and Mainland China, signals the acceptance of Infobird’s standardized SaaS products by the retail industry and large enterprises. By shifting from customized SaaS modules to standardized SaaS modules in order to offer products and services to both mid-to-large enterprises and small-to-medium-sized enterprises (“SMEs”) in China, Infobird became the first SaaS company in the country capable of serving all types of enterprises. Ultimately, the company intends to leverage its standardized modules’ quick and easy roll-out and scalability to capture the lion’s share of China’s SaaS market (https://ibn.fm/ZimSz). The strategic transformation has enabled Infobird to quickly expand and diversify its client base to include more industry sectors – a factor that influenced its projection that revenue for the fiscal year 2021 will increase by more than 50% year over year to between $22 million and $25 million. Based on its progress thus far, Infobird is ideally positioned to realize its goal of capturing the market share, all while making customer experience leaders out of clients such as SaSa Cosmetics (China) Co., Ltd. For more information, visit the company’s website at www.Infobird.com/en/index.html. NOTE TO INVESTORS: The latest news and updates relating to IFBD are available in the company’s newsroom at https://ibn.fm/IFBD

• HYEX’s portfolio of wholly owned subsidiaries currently comprises BergametNA and Ultimate Brain Nutrients
• BergametNA, whose products target cardiovascular and immune health, sources its formulations from the Citrus Bergamot SuperFruit(TM)
• The bergamot fruit is richly packed with polyphenolic flavanones, which are known to decrease bad cholesterol, triglyceride, and glucose, as well as increase the good cholesterol
• BergaMet only uses the highest concentration of polyphenolic flavanones (“BPF”) as the higher the BPF, the greater the effectiveness of the supplement

Guided by the philosophy ‘Live Life Young Again’ and its commitment to superior health technology by engaging in the R&D of natural plant-based formulations, Healthy Extracts (OTCQB: HYEX), through its portfolio of wholly owned subsidiaries that currently comprises Ultimate Brain Nutrients (“UBN”) and BergametNA, develops, sells, and distributes proprietary products with proven health benefits. As UBN creates formulations that improve brain health, including memory, cognition, focus, and neuro-energy, BergametNA’s focus is primarily on the development of powerfully proven supplements, sourced from the Citrus Bergamot SuperFruit(TM) (“bergamot”) and which target cardiovascular and immune health. Native to the Calabria region of Southern Italy, bergamot has a host of health benefits as it is a source of high concentrations of polyphenolic flavanones, measured in terms of the bergamot polyphenolic fraction (“BPF”). According to Dr. Gerald Haase, MD, a clinical professor of surgery at the University of Colorado School of Medicine, the BPF in bergamots ranges from 30% to 47% (https://ibn.fm/74Mcl). The fruit’s five key polyphenolic flavanones perform the following specific actions that offer human health benefits:

• They activate AMP kinase, which is a master regulator of glucose and fatty acid metabolism
• By acting like HMG-CoA reductase inhibitors (“statins”), they block the mevalonate pathway (“MP”), which is known to synthesize cholesterol, thereby decreasing the amount of cholesterol made in the body
• They inhibit phosphodiesterase 3B, thus improving cardiac and overall performance by promoting vasodilation (blood vessel dilation) and smooth relaxation of the heart and lung muscles

Bergamot’s polyphenolic flavanones act just like statins and even have similar health benefits. However, while statins are known to cause side effects, some potentially severe, the compounds drawn from bergamots and, by extension, the supplements are considered safer and better. Further, more than a dozen clinical studies and independent research have proven bergamot’s benefits as regards its ability to deal with cardiovascular disease, metabolic syndrome, and non-alcoholic fatty liver disease. Summarizing some of the findings, Dr. Haase noted: “With regard to metabolic syndrome, with or without fatty liver disease… total cholesterol and LDL cholesterol go down 25-35%, triglycerides go down more than 30%, glucose goes down around 20%, and the good cholesterol goes up by up to 40%.” “In non-alcoholic fatty liver disease, there is dramatic improvement in dyslipidemia, decrease in oxidative damages, and there are decreases in liver enzyme levels. Glucose metabolism is also enhanced,” Dr. Haase added. Dr. Haase further observes that the higher the BPF, the greater the supplement’s effectiveness. With BergametNA only using the bergamots with the highest BPF (47%), customers are guaranteed to extract more out of the powerfully proven plant-based supplements than from competitors’ products, which are sourced from bergamots whose BPF concentrations range between 30% and 37% (https://ibn.fm/JsjrA). When Healthy Extracts Inc. (HYEX) formally changed its name from Grey Cloak Tech Inc. early this year, its resolve to primarily develop plant-based, proprietary nutraceuticals and neuro-products was clear. This commitment indeed continues and is embodied by the effective supplements the company continues to avail to its customers. For more information, visit the company’s website at www.HealthyExtractsInc.com. NOTE TO INVESTORS: The latest news and updates relating to HYEX are available in the company’s newsroom at https://ibn.fm/HYEX About Healthy Extracts Inc. “Live Life Young Again” Healthy Extracts Inc. (OCTQB: HYEX) serves as a platform for developing and acquiring complementary companies that feature science-forward, clinically proven, plant-based and proprietary products in select high-margin and high-growth categories within the multibillion-dollar nutraceuticals market – the first two multimillion-dollar examples of which have already been launched. Company subsidiaries BergametNA(TM) and Ultimate Brain Nutrients(TM) (“UBN”) are providers of nutraceutical natural heart and brain health supplements, including the only heart health supplement containing Citrus Bergamot SuperFruit(TM), the highest quality and concentration of polyphenols and flavonoids available anywhere in the world and exclusive to BergametNA in North America and backed by 17 clinical studies. UBN’s KETONOMICS(R) proprietary formulations improve brain health, including memory, cognition, focus and neuro-energy, and have multiple intellectual property license opportunities for monetizing the company’s portfolio. UBN has six unique formulation patents – two issued and four pending. For more information, visit: www.healthyextractsinc.com or www.bergametna.com. Forward-Looking Statements and Safe Harbor Notice All statements other than statements of historical facts included in this press release are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as “projected,” “expect,” “possibility” and “anticipate.” The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the Company’s Annual Report on Form 10-K filed with the SEC on April 1, 2020, and future periodic reports filed with the SEC. All of the Company’s forward-looking statements are expressly qualified by all such risk factors and other cautionary statements. The Company cautions that statements and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only as of the date hereof. The Company and its management undertake no obligation to revise these statements following the date of this news release. Healthy Extracts Inc. Las Vegas, Nevada www.healthyextractsinc.com info@healthyextractsinc.com 720-463-1004 Corporate Communications: InvestorBrandNetwork (“IBN”) Los Angeles, California www.InvestorBrandNetwork.com 310.299.1717 Office Editor@InvestorBrandNetwork.com

• Marijuana sales in Michigan hit record $115.4 million in March, more than twofold increase over March 2020
• U.S. marijuana markets forecasted to reach an estimated $45.9 billion in annual sales by 2025
• HENC focused on developing “largest vertically integrated cannabis company the world has ever known”

The numbers being reported in Michigan’s cannabis space are impressive, and companies operating in the state, such as Hero Technologies (OTC: HENC), are watching the growth of the industry closely. The state’s numbers should only increase as the cannabis market in the United States hits record highs. “Recreational and medical marijuana sales in the state hit a record $115.4 million in March, a more than two-fold increase over March 2020, according to Headset, a company that analyzes cannabis consumer trends,” reported a recent Detroit Metro Times article (https://ibn.fm/lsVMA). “There were 1.4 million transactions in March.” The article also noted that in 2020, the first full year of legal recreational sales, Michigan dispensaries reported more than $500 million in purchases, with sales declining slightly late last year. “But in early 2021, sales not only rebounded, they began to soar to record levels,” the article continued. “That growth is expected to continue.” The most recent Marijuana Business Factbook reports that “the U.S. recreational and medical marijuana markets are on a trajectory to reach up to $45.9 billion in annual sales by 2025, or as much as twice the level of sales projected for this year. . . . U.S. adult-use and medical cannabis sales in 2021 are expected to reach $22 billion–$26.4 billion” (https://ibn.fm/TcwcF). With U.S. and Michigan numbers heading skyward, Hero Technologies appears to be ideally positioned in the burgeoning market. “We are growers and cultivators, developers, builders, engineers, marketers, and managers all here to serve Hero Technologies Inc. as we rapidly develop the largest vertically integrated cannabis company the world has ever known,” proclaims the company website (https://ibn.fm/uTNor). And while that statement may seem lofty, a closer look at the company reveals a portfolio of companies that provide superior cultivation and dispensary assets. HENC’s portfolio includes a majority stake in BlackBox Systems and Technologies LLC., an aeroponic cannabis cultivation system that provides optimal conditions to enhance photosynthesis and cultivation of large flowering plants, creating increased efficiencies. Hero Technologies is planning expansion of cultivation and dispensary operations into Massachusetts through wholly owned subsidiary MassCannabis LLC. In addition, Hero Technologies owns and operates two hemp websites: HighlyRelaxing.com under Highly Relaxing LLC and VeteranHempCo.com. Hero Technologies Inc. is a cannabis company working toward a vertically integrated business model. The company’s strategic business plan includes cannabis genetic engineering, farmland for both medical and recreational cannabis cultivation, production licenses, distribution licenses, consumer packaging, and retail and dispensary operations that make the company a multistate operator. For more information, visit the company’s website at www.HeroTechnologiesInc.com. NOTE TO INVESTORS: The latest news and updates relating to HENC are available in the company’s newsroom at https://ibn.fm/HENC

• FingerMotion Inc. reported total annual revenue of $16.68 million for the 2021 financial year ended February 28, 2021
• This FYE 2021 results represented an 82% growth from the FYE 2020 results
• The company also posted $2.11 million in positive shareholders’ equity
• The growth was attributed to an increase in subscriber numbers, resource optimization, and the mix between Top-up and SMS product and service offerings

Founded in 2016 as a mobile gaming enterprise, FingerMotion (OTCQX: FNGR) has become a leading mobile services and data company. In the 2021 financial year, FingerMotion, Inc posted its highest revenue and year-over-year revenue growth thus far, as indicated in its reports for the fiscal year ending February 28, 2021. According to the press release (https://ibn.fm/Wss7I) dated June 2, 2021, FingerMotion Inc. reported annual revenue of $16.68 million, an 82% growth from the previous financial year 2020. Its SMS and MMS segment posted business revenue of $6.13 million for the 2021 fiscal year, an 84% growth from the year prior. This growth showed the company’s commitment to innovation and streamlining its operations for the overall development of the enterprise. FingerMotion Inc.’s fourth quarter for the 2021 fiscal year generated revenue totaling $5.43 million in its third consecutive quarter of record revenue. “The company recently announced that Top-up revenue could increase by as much as 1000% and that SMS revenue could increase by 20-30% in FYE 2022,” said Shen in a statement accompanying the announcement. The 2021 impressive fiscal performance was mainly attributed to the company’s commitment to growth in its subscribers, a factor that, Mr. Shen noted, will further allow for the increase in revenue for the coming financial year. Additionally, Mr. Shen stated that the company’s resolve to expand into new regions, coupled with fostering solid relationships with other players in the telecommunications industry, is set to guarantee its platform’s reliability and spur customer loyalty. FingerMotion Inc. is also dedicated to research and development. In the 2021 financial year, it spent $0.55 million, a 42% increase from the previous financial year in the research and development of new products for its customers. Going forward, the company seeks to invest in its Big Data Insights division, an investment that will yield multiple contracts relating to its Insuretech line of products.  In the 2021 fiscal year, FingerMotion’s Big Data business reported first revenues of $33,077, with prospects for further growth in the coming financial year. This shows FingerMotion’s pledge to innovation and its overall outlook on the opportunities that currently exist in the market. In terms of profit, FingerMotion ended its 2021 financial year with a 71% growth. Shen attributed this progression to its resource optimization and its delicate mix between Top-up and SMS product and service offerings. He noted, however, that the company’s biggest challenge currently is access to non-dilutive capital. The company’s overall growth for the 2021 financial year was great news for shareholders, having posted $2.11 million in positive shareholders’ equity. “For FingerMotion’s shareholders, this is a big step forward because many senior exchanges require a certain amount of positive shareholders’ equity to qualify under listing standards,” said Martin J. Shen. As the company continues to evolve and innovate, the future looks bright for FingerMotion Inc. The 2022 financial year continues to develop additional value-added technologies to appeal more to its users. The company’s overall vision is to rapidly yet organically grow the user base and have this growth morph into an ecosystem of users with high engagement rates utilizing its innovative applications. Every segment of FingerMotion Inc’s offerings feeds into the other. The company hopes this is the ecosystem that will eventually serve over 1 billion users, starting with the Chinese market before finally expanding to other regional markets. For more information, visit the company’s website at www.FingerMotion.com. NOTE TO INVESTORS: The latest news and updates relating to FNGR are available in the company’s newsroom at https://ibn.fm/FNGR

Date: June 15-17, 2021 Virtual Event Event Highlights

• The conference aims to ensure compliant pre-market and post-market operations
• The event will feature case studies, panel discussions, and presentations by 15+ industry professionals holding senior positions at various pharmaceutical and biotechnology companies
• Attendees should expect to get their unique needs addressed as the program includes Q&A sessions after every discussion
• There will be 30-minute virtual networking sessions daily

As an organizer whose mission is to propel highly regulated industries forward through platforms of curated executive learning with a focus on quality, Q1 Productions invites you to one such platform: the 7th Annual Global Regulatory Affairs CMC: Chemistry, Manufacturing, and Controls Conference, a virtual event to be held on June 15-17, 2021. The conference aims to ensure compliant pre-market and post-market operations using comprehensive product lifecycle management strategies and strict supply chain change-control processes. In this regard, it will explore the evolution of products throughout their lifecycle and discuss guideline changes, as well as the challenges emanating from global regulatory harmonization. Designed to better equip CMC teams with knowledge on how to deliver uninterrupted product supply chains, streamline approval processes, and showcase products’ efficacy, quality, and chemical makeup in an evidence-based manner, the virtual conference will feature case studies, panel discussions, and presentations, all facilitated by industry professionals. To maximize knowledge acquisition and engagement, the learning will be delivered in three half-day modules scheduled from 9:30 am to 1:15 pm CST. Module 1 will have nine facilitators holding executive positions at various pharmaceutical and biotechnology companies wherein they oversee regulatory affairs or CMC operations. The conference, to be held on the Q1 Productions virtual event app, will kick off with a keynote panel in which five panelists will examine the topic Navigating the Continually Dynamic CMC Landscape. Day 1 will include three additional presentations and a 30-minute virtual networking session and coffee break. Module 2 will pick up where the facilitators will left on day one by exploring the regulatory approvals in Brazil and China. Like the first day, the second day will also feature a virtual networking session and coffee break, followed by a presentation by the Head, Global Chemistry, Manufacturing & Controls at Merck (NYSE: MRK), Ganapathy Mohan, who will decode the standards related to nitrosamine data requirements. Later, Christina Markus, Deputy Chair, FDA & Life Sciences Practice at King and Spalding, will discuss the CMC development and regulatory considerations for cell and gene therapies, the last presentation of the day. Module 3 will feature two presentations and a session series titled Quality and regulatory requirements for a product’s starting materials, in which presenters Arul Joseph, the Senior Director, Pharmaceutical Development & Clinical Supply Chain at Avanir Pharmaceuticals and Ambarish Singh, the Head of Regulatory CMC at Constellation Pharmaceuticals (NASDAQ: CNST), will each present case studies. Attendees should expect to gain insights and a comprehensive understanding of regulatory affairs in CMC and learn from industry experts with many years’ experience currently holding senior positions in their respective companies. What’s more, attendees will get to customize their experiences and seek answers to their unique concerns and questions during live Q&A sessions after each discussion. They should also anticipate interactive and fun sessions owing to Q1 Productions’ emphasis on using different types of session formats, as well as scheduling virtual networking sessions. With all these characteristics, the event indeed espouses Q1 production’s mantra – Dedicated to Quality First. For more information regarding the event, please visit https://ibn.fm/vpOjH